Thursday, February 18, 2010
NUEVA INFORMACION DE SEMINARIOS
El doctor George M. Suárez va a conducir un seminario en el Hotel Biltmore de Coral Gables. Será en el mes de Marzo. Ya les informaremos mas adelante.
Monday, February 15, 2010
LATEST INFORMATION - POST BY GEORGE M. SUAREZ, M.D.
HIFU machines
by alady on Sun Feb 14, 2010 12:22 AMQuote Reply
There are two machines.
The Ablatherm, which is made in France, and is robotic. The doctor inserts the wand up the rectum, clamps it down so it is secure, then he sets the margins and the machine cooks the tissue, leaving the shell of the prostate. The Ablatherm is capable of cooking a 25cc gland is has a 2.5cm focal length beam. This machine's short beam reach means most men need to undergo a gland reducing procedure, most often a TURP (rooto rooter) which can cause scarring and lead to incontinence. Green light lazer is a new technique, which is cheap and pain free, but isn't offered in many places in the USA. Or hormone treatment will reduce the size. The Ablatherm is capable of cooking a 25cc gland is has a 2.5cm focal length beam. The Ablatherm is not capable of monitoring neurovascular blood flow, or detecting the neurovascular bundles and it only gives the doctor one view of the prostate, not 3-D. It's treatment lesion is larger.
The Sonablate is made in America, Indiana. It is manual with a bit of a robotic capability. The doctor inserts the wand up the rectum and clamps it down so it is secure, there's no movement. Then he uses the computer screen which allows him to see multiple views of the prostate including 3D images. He watches his progress as he moves the ray of sound to cook the tissue, if any tissue is left the machine can see it and report it to the doctor. It also leaves the shell of the prostate intact. It can cook a prostate up to 40cm as it's focal length is 4.0. If your gland is over 40cm then one of the gland reducing methods mentioned above will be needed. The Sonablate is able to monitor blood flow through the neurovascular bundles with a color overlay during both planning and treatment. Through detecting the blood flow, physicians can clearly see the location of the neurovascular bundles, thus avoiding them to preserve potency. The doctor can control the power level of the Sonablate and it's treatment lesion is smaller, leading to a more percise treatment lesion.
HIFU is capable of treating recurrent prostate cancer after radiation failure.
HIFU takes 1-3 hours for treatment. Then a wake up period of 1-2 hours as you are put to sleep, to prevent any movement, sneezing, etc.
Dr. T Uchida has recently presented and published data using the Sonablate that showed Biochemical Disease Free Rate After 5 Years: Low Risk 97%, Intermediate Risk 71%, High Risk 64%
Find: Clinical Outcome of HIFU for the Treatment of localized prostate cancer: 5-year Experience. Toyoaki Uchida, Hiroshi Ohkusa, Hideyuki Yamashita, Yoshihiro Nagata Department of Urology, Tokai University Hachioji Hospital. Abstract - ISTU 2004
.......and my husband is doing great after HIFU!!
Quote Reply
Share
1 Posts Page(s): 1
Track this discussion
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
Track Discussion
Stop tracking this discussion
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
Stop Tracking
Subscribe to this message board discussion
Latest Messages
concerned about 14yo son..help... posted 3 minutes ago by judew
RE: Help please...more enlarge... posted 5 minutes ago by pjane
RE: Dex and smoking? posted 7 minutes ago by Dstew
RE: Advice about swollen feet.... posted 19 minutes ago by daddyslilgirl31
RE: Low iodine brands? posted 29 minutes ago by dinparadise
CancerCompass Poll
Do you ever feel like you need to advice about frustrations or touchy situations related to cancer?
Not too often
Sometimes
Most of the time
by alady on Sun Feb 14, 2010 12:22 AMQuote Reply
There are two machines.
The Ablatherm, which is made in France, and is robotic. The doctor inserts the wand up the rectum, clamps it down so it is secure, then he sets the margins and the machine cooks the tissue, leaving the shell of the prostate. The Ablatherm is capable of cooking a 25cc gland is has a 2.5cm focal length beam. This machine's short beam reach means most men need to undergo a gland reducing procedure, most often a TURP (rooto rooter) which can cause scarring and lead to incontinence. Green light lazer is a new technique, which is cheap and pain free, but isn't offered in many places in the USA. Or hormone treatment will reduce the size. The Ablatherm is capable of cooking a 25cc gland is has a 2.5cm focal length beam. The Ablatherm is not capable of monitoring neurovascular blood flow, or detecting the neurovascular bundles and it only gives the doctor one view of the prostate, not 3-D. It's treatment lesion is larger.
The Sonablate is made in America, Indiana. It is manual with a bit of a robotic capability. The doctor inserts the wand up the rectum and clamps it down so it is secure, there's no movement. Then he uses the computer screen which allows him to see multiple views of the prostate including 3D images. He watches his progress as he moves the ray of sound to cook the tissue, if any tissue is left the machine can see it and report it to the doctor. It also leaves the shell of the prostate intact. It can cook a prostate up to 40cm as it's focal length is 4.0. If your gland is over 40cm then one of the gland reducing methods mentioned above will be needed. The Sonablate is able to monitor blood flow through the neurovascular bundles with a color overlay during both planning and treatment. Through detecting the blood flow, physicians can clearly see the location of the neurovascular bundles, thus avoiding them to preserve potency. The doctor can control the power level of the Sonablate and it's treatment lesion is smaller, leading to a more percise treatment lesion.
HIFU is capable of treating recurrent prostate cancer after radiation failure.
HIFU takes 1-3 hours for treatment. Then a wake up period of 1-2 hours as you are put to sleep, to prevent any movement, sneezing, etc.
Dr. T Uchida has recently presented and published data using the Sonablate that showed Biochemical Disease Free Rate After 5 Years: Low Risk 97%, Intermediate Risk 71%, High Risk 64%
Find: Clinical Outcome of HIFU for the Treatment of localized prostate cancer: 5-year Experience. Toyoaki Uchida, Hiroshi Ohkusa, Hideyuki Yamashita, Yoshihiro Nagata Department of Urology, Tokai University Hachioji Hospital. Abstract - ISTU 2004
.......and my husband is doing great after HIFU!!
Quote Reply
Share
1 Posts Page(s): 1
Track this discussion
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
Track Discussion
Stop tracking this discussion
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
Stop Tracking
Subscribe to this message board discussion
Latest Messages
concerned about 14yo son..help... posted 3 minutes ago by judew
RE: Help please...more enlarge... posted 5 minutes ago by pjane
RE: Dex and smoking? posted 7 minutes ago by Dstew
RE: Advice about swollen feet.... posted 19 minutes ago by daddyslilgirl31
RE: Low iodine brands? posted 29 minutes ago by dinparadise
CancerCompass Poll
Do you ever feel like you need to advice about frustrations or touchy situations related to cancer?
Not too often
Sometimes
Most of the time
TO ALL MY BROTHERS AND SISTERS
Dear Brothers and Sisters,
PROSTATE CANCER is the most common cancer in men and the second leading cause of cancer related deaths. If detected early it can be successfully treated using one or more of the accepted treatment options. Options are radiation, proton beam, radical, robotic, and cryo. All of these treatments have had success in destroying the cancer. Unfortunately all these treatment have high incidences of collateral damage. Incontinence, impotence, and recurrence are fairly common and are of great concern for patients after the procedure. Several of our brothers have had to be treated for prostate cancer and they have used more than one of the above treatments. The side effects can be as devastating to the patient as the cancer. Once the cancer is resolved which of these treatments will allow us to return to a normal life as quickly as possible. For this reason I write this article.
I have witnessed the devastating effects the robotic treatment had on one of our brothers and I would like to tell all of you, so you can pass it on to a family member or friend. There is a treatment that is available but is not widely known about. That treatment is high intensity focused ultrasound (HIFU). This treatment which is still not accepted as of yet by the FDA but is being done all over the world has provided several of our brothers with remarkable results. These brothers are returning to a full and fulfilling life very quickly with minimal or no issues. I have not mentioned any names because in this format I believe it to be inappropriate. All of the guys that had HIFU are extremely happy and willing to speak to anyone that might have questions. The brother that had the robotic treatment asked me to get this message out because of my relationship with the Doctor that started HIFU. He wishes someone had told him about this procedure so he would have had information about the different options available.
U.S. citizens have to go to either Nassau, Mexico, or Canada to have this procedure done. Do not let that scare you as these facilities are top of the line and a Doctor from the U.S. will be there to do the procedure. I am not saying there will never be a negative side effect with this procedure but for the guys that have had it there is no negatives. As a person that plays the odds this would be the procedure for me and this is the procedure I would direct my family towards. Insurance companies are actually picking up the tab for this procedure.
Dr. George Suarez is the founder of USHIFU and has treated over two thousand men and several of our own. He conducts seminars each month at the Biltmore Hotel in Coral Gables where he discusses all treatment options. He is a personal friend of mine who is helping our brothers and I wish to let as many people as possible know about this seemingly wonderful procedure. If you have any questions call me Jim Bruce at 305-773-1986.
PROSTATE CANCER is the most common cancer in men and the second leading cause of cancer related deaths. If detected early it can be successfully treated using one or more of the accepted treatment options. Options are radiation, proton beam, radical, robotic, and cryo. All of these treatments have had success in destroying the cancer. Unfortunately all these treatment have high incidences of collateral damage. Incontinence, impotence, and recurrence are fairly common and are of great concern for patients after the procedure. Several of our brothers have had to be treated for prostate cancer and they have used more than one of the above treatments. The side effects can be as devastating to the patient as the cancer. Once the cancer is resolved which of these treatments will allow us to return to a normal life as quickly as possible. For this reason I write this article.
I have witnessed the devastating effects the robotic treatment had on one of our brothers and I would like to tell all of you, so you can pass it on to a family member or friend. There is a treatment that is available but is not widely known about. That treatment is high intensity focused ultrasound (HIFU). This treatment which is still not accepted as of yet by the FDA but is being done all over the world has provided several of our brothers with remarkable results. These brothers are returning to a full and fulfilling life very quickly with minimal or no issues. I have not mentioned any names because in this format I believe it to be inappropriate. All of the guys that had HIFU are extremely happy and willing to speak to anyone that might have questions. The brother that had the robotic treatment asked me to get this message out because of my relationship with the Doctor that started HIFU. He wishes someone had told him about this procedure so he would have had information about the different options available.
U.S. citizens have to go to either Nassau, Mexico, or Canada to have this procedure done. Do not let that scare you as these facilities are top of the line and a Doctor from the U.S. will be there to do the procedure. I am not saying there will never be a negative side effect with this procedure but for the guys that have had it there is no negatives. As a person that plays the odds this would be the procedure for me and this is the procedure I would direct my family towards. Insurance companies are actually picking up the tab for this procedure.
Dr. George Suarez is the founder of USHIFU and has treated over two thousand men and several of our own. He conducts seminars each month at the Biltmore Hotel in Coral Gables where he discusses all treatment options. He is a personal friend of mine who is helping our brothers and I wish to let as many people as possible know about this seemingly wonderful procedure. If you have any questions call me Jim Bruce at 305-773-1986.
Wednesday, February 10, 2010
LOUIS GOSSET JR. DIAGNOSED WITH PROSTATE CANCER
Louis Gossett Jr. Has Prostate Cancer
By Stephen M. Silverman
Wednesday February 10, 2010 09:00 AM EST
Louis Gossett Jr.
John Shearer/WireImage
tiiQuigoWriteAd(757767, 1348106, 180, 240, -1);
Yahoo Buzz
E-mail Louis Gossett Jr. has done the right thing regarding his prostate cancer: He received an early diagnosis and he is acting promptly. As a result, the Supporting Actor Oscar winner – for 1983's An Officer and a Gentleman, in addition to his Emmy for 1977's Roots – expects to receive the greatest prize of all: a full recovery. Gossett, 73, says he is spreading awareness of his condition because of the lack of emphasis in the African-American community on fighting the highly treatable (and extremely common) form of cancer. The best way to fight it is preventive examinations and early treatment, which can involve surgery and/or radiation.For more information on prostate cancer, visit the Prostate Cancer Foundation Web site. For more information on Gossett, his memoir, An Actor and a Gentleman, is due to be published on May 10.
See what other readers have to say about this story – or leave a comment of your own
Monday, February 8, 2010
Canada’s New Democratic Leader Layton Has Cancer (Update1)
Share Business ExchangeTwitterFacebook Email Print A A A
By Greg Quinn
Feb. 5 (Bloomberg) -- Jack Layton, leader of Canada’s opposition New Democratic Party, said he’s been diagnosed with prostate cancer and will remain in the job as he seeks treatment.
“My treatment plan is now under way,” Layton, 59, told reporters in Toronto today. “I will be carrying on” as party leader, he said.
Layton’s father had the same type of cancer, and he “fought it and won,” Layton said. Olivia Chow, Layton’s wife and a New Democratic member of Parliament from Toronto, has battled cancer too, he said.
Layton has led the New Democrats since January 2003, when the party had 14 seats in the House of Commons. Their total has increased to 37, of the 308 seats in the chamber.
Layton has sought increased spending on jobless benefits and said he would support Prime Minister Stephen Harper’s governing Conservatives as long as Parliament was “working.” Harper’s Conservatives hold a minority of seats and need at least one opposition party to pass legislation and stay in power.
To contact the reporter on this story: Greg Quinn in Ottawa at gquinn1@bloomberg.net. Last Updated: February 5, 2010 15:33 EST
Business Exchange
Twitter
Delicious
Digg
Facebook
LinkedIn
Newsvine
Propeller
Share Business ExchangeTwitterFacebook Email Print A A A
By Greg Quinn
Feb. 5 (Bloomberg) -- Jack Layton, leader of Canada’s opposition New Democratic Party, said he’s been diagnosed with prostate cancer and will remain in the job as he seeks treatment.
“My treatment plan is now under way,” Layton, 59, told reporters in Toronto today. “I will be carrying on” as party leader, he said.
Layton’s father had the same type of cancer, and he “fought it and won,” Layton said. Olivia Chow, Layton’s wife and a New Democratic member of Parliament from Toronto, has battled cancer too, he said.
Layton has led the New Democrats since January 2003, when the party had 14 seats in the House of Commons. Their total has increased to 37, of the 308 seats in the chamber.
Layton has sought increased spending on jobless benefits and said he would support Prime Minister Stephen Harper’s governing Conservatives as long as Parliament was “working.” Harper’s Conservatives hold a minority of seats and need at least one opposition party to pass legislation and stay in power.
To contact the reporter on this story: Greg Quinn in Ottawa at gquinn1@bloomberg.net. Last Updated: February 5, 2010 15:33 EST
Business Exchange
Delicious
Digg
Newsvine
Propeller
Tuesday, February 2, 2010
Monday, February 1, 2010
Article Posted by Dr. Suarez
Background
The potential therapeutic uses of ultrasound energy in cardiac disease have not been extensively studied. We have developed a means to deliver high-intensity focused ultrasound (HIFU) to myocardial tissue. Unlike other therapy modalities such as radiofrequecy catheter ablation, this system has the advantages of not requiring direct tissue contact and the ability to focus intense energy within a small volume.
Methods
Sections of left and right ventricles from freshly excised canine hearts were treated in vitro with HIFU pulses. Lesions were created using 1-second HIFU pulses with ultrasonic powers ranging from 19.8 to 45.8 W.
Results
There was a dose-response relationship between the applied HIFU energy and lesion size (r = 0.70, P < .001). Myocardial lesion formation with HIFU was also performed in vivo in a canine open-chest beating heart model. With 200-millisecond HIFU pulses gated to the electrocardiogram, focal myocardial lesions were created ranging in length from 2 to 6 mm depending on the dose used. Furthermore, both in vitro and in vivo, focal lesions were successfully formed in the midmyocardial wall that spared both the endocardial and epicardal surfaces.
Conclusion
HIFU is a novel means to create focal myocardial lesions without direct tissue contact. HIFU energy delivery can be gated to the electrocardiogram in an in vivo model, and lesions can be formed intramyocardially. Further application of this technology may prove to be useful for the ablation of myocardial lesions such as arrhythmogenic foci and the hypertrophic ventricular septum in hypertrophic cardiomyopathy.
The potential therapeutic uses of ultrasound energy in cardiac diseases have not been well studied. We tested a novel system to deliver high-intensity focused ultrasound energy in vitro and in vivo to canine myocardial samples without direct contact with the target tissue. Focal myocardial lesions were formed in a dose-dependent manner, and myocardial lesions were created. This technology may prove useful for ablation of focal intramyocardial lesions such as arrhythmogenic foci and the hypertrophic left ventricular septum in hypertrophic cardiomyopathy.
a Division of Cardiology, Columbia Presbyterian Medical Center, New York, New York, USA.
b Riverside Research Institute, New York, New York, USA.
Reprint requests: Shunichi Homma, MD, Columbia Presbyterian Medical Center, 622 W 168th St, PH 3-342, New York, NY 10032.
Supported in part by: (1) Bioengineering Research Partnerships grant 5RO1 CA84588 from the National Cancer Institute and the National Heart, Lung, and Blood Institute (NHLBI); and (2) Cardiovascular Fellowship Training grant T32HL07854 from NHLBI.
PII: S0894-7317(06)00258-6
doi:10.1016/j.echo.2006.02.012
© 2006 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.
21 of 29
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.
The potential therapeutic uses of ultrasound energy in cardiac disease have not been extensively studied. We have developed a means to deliver high-intensity focused ultrasound (HIFU) to myocardial tissue. Unlike other therapy modalities such as radiofrequecy catheter ablation, this system has the advantages of not requiring direct tissue contact and the ability to focus intense energy within a small volume.
Methods
Sections of left and right ventricles from freshly excised canine hearts were treated in vitro with HIFU pulses. Lesions were created using 1-second HIFU pulses with ultrasonic powers ranging from 19.8 to 45.8 W.
Results
There was a dose-response relationship between the applied HIFU energy and lesion size (r = 0.70, P < .001). Myocardial lesion formation with HIFU was also performed in vivo in a canine open-chest beating heart model. With 200-millisecond HIFU pulses gated to the electrocardiogram, focal myocardial lesions were created ranging in length from 2 to 6 mm depending on the dose used. Furthermore, both in vitro and in vivo, focal lesions were successfully formed in the midmyocardial wall that spared both the endocardial and epicardal surfaces.
Conclusion
HIFU is a novel means to create focal myocardial lesions without direct tissue contact. HIFU energy delivery can be gated to the electrocardiogram in an in vivo model, and lesions can be formed intramyocardially. Further application of this technology may prove to be useful for the ablation of myocardial lesions such as arrhythmogenic foci and the hypertrophic ventricular septum in hypertrophic cardiomyopathy.
The potential therapeutic uses of ultrasound energy in cardiac diseases have not been well studied. We tested a novel system to deliver high-intensity focused ultrasound energy in vitro and in vivo to canine myocardial samples without direct contact with the target tissue. Focal myocardial lesions were formed in a dose-dependent manner, and myocardial lesions were created. This technology may prove useful for ablation of focal intramyocardial lesions such as arrhythmogenic foci and the hypertrophic left ventricular septum in hypertrophic cardiomyopathy.
a Division of Cardiology, Columbia Presbyterian Medical Center, New York, New York, USA.
b Riverside Research Institute, New York, New York, USA.
Reprint requests: Shunichi Homma, MD, Columbia Presbyterian Medical Center, 622 W 168th St, PH 3-342, New York, NY 10032.
Supported in part by: (1) Bioengineering Research Partnerships grant 5RO1 CA84588 from the National Cancer Institute and the National Heart, Lung, and Blood Institute (NHLBI); and (2) Cardiovascular Fellowship Training grant T32HL07854 from NHLBI.
PII: S0894-7317(06)00258-6
doi:10.1016/j.echo.2006.02.012
© 2006 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.
21 of 29
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.
Subscribe to:
Posts (Atom)